SlideShare a Scribd company logo

Q3 15 earnings slides-final

Q3 15 earnings slides-final

1 of 26
Download to read offline
Bruker Corporation (NASDAQ: BRKR)
Q3 2015 Earnings Presentation
Frank Laukien, President & CEO
Anthony Mattacchione, SVP & Interim CFO
Joshua Young, VP, IR & Corporate DevelopmentNovember 4, 2015
Innovation with Integrity
Any statements contained in this presentation that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995.
Any forward-looking statements contained herein are based on current expectations, but are subject to
risks and uncertainties that could cause actual results to differ materially from those projected, including,
but not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy
and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the
future, our ability to successfully implement restructuring initiatives, changing technologies, product
development and market acceptance of our products, the cost and pricing of our products,
manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending
and government funding policies, changes in governmental regulations, realization of anticipated benefits
from economic stimulus programs, intellectual property rights, litigation, and exposure to foreign
currency fluctuations and other risk factors discussed from time to time in our filings with the Securities
and Exchange Commission. These and other factors are identified and described in more detail in our
filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended
December 31, 2014 and our quarterly reports on Form 10-Q for the periods ended March 31, 2015 and
June 30, 2015. We will also be referencing non-GAAP financial measures in this presentation. A
reconciliation of non-GAAP to GAAP results is available in our earnings press release and in this
presentation.
Bruker Corporation
Safe Harbor & Reg. G Statement
© Bruker Corporation 2
Q3-15 & YTD 2015 Business Update
© Bruker Corporation 3
$0.14
$0.19
Q3-14
Q3-15
Q3 Financials
Revenues [$ m]
Non-GAAP EPS
Bruker delivers stronger, more balanced financial
performance in Q3 2015
-6%
+36%
© Bruker Corporation 4
420 396
Q3-14 Q3-15
Q3 2015 Performance
 Revenues decline -$24m, or -6% y-o-y
− FX headwinds lower revenue -11% y-o-y
 Organic revenue growth of +8% y-o-y, driven
by CALID and BioSpin Groups
− Europe & Asia are strongest regions
 Non-GAAP operating margins expand by +470
basis points y-o-y
 Non-GAAP EPS grows by +36% y-o-y despite
higher tax rate
 Free cash flow of $45M in Q3-15 up compared
to $4M in Q3-14
− Higher profitability and lower working
capital drive FCF improvement
$0.46
$0.51
YTD 2014
YTD 2015
YTD Financials
Revenues [$ m]
Non-GAAP EPS
Q3-YTD Bruker is on track for a year of good margin
expansion, earnings growth and cash flow generation
-12%
+11%
© Bruker Corporation 5
1,301
1,146
YTD 14 YTD 15
Q3 YTD 2015 Performance
 Revenues decline -12% y-o-y
 Organic revenue growth of +2% y-o-y
1.High-single digit organic revenue growth
from CALID Group; low single digit
organic revenue growth in NANO Group
2.Low single digit organic revenue decline
in BioSpin Group
3.Europe and Asia drive YTD organic growth
 Non-GAAP operating margin expands by +220
basis points y-o-y, including +115 basis points
due to CAM restructuring in 2014
 Reported non-GAAP EPS grows +11%
 Free cash flow of $57M increases by +$39
million, compared to $18M in Q3 YTD 2014
Bruker BIOSPIN Group
 Strong revenue growth for Nuclear Magnetic Resonance (NMR) as
business rebounds in all major geographies
 NMR business recovery continues as order bookings remain healthy
 Preclinical imaging business reports mid-single digit organic growth
in Q3-15, but YTD weakness in order bookings continues
 Positive product mix, benefits from restructuring, higher-margin
transactions, earlier than expected customer acceptances drive
improved margins
Bruker CALID Group
 Delivers double-digit organic revenue growth y-o-y with strong
performance in Europe and Asia, and with strong margin expansion
 Daltonics Division drives organic revenue growth in nearly all product
lines and geographies
 Detection Division generates exceptional, but non-recurring revenue
growth in Q3-15 with new explosives trace detection products
 Optics Division experiences flat organic revenues due to restrained
demand from industrial and high-end R&D customers
6© Bruker Corporation
GROUP OVERVIEW:
Q3 2015 Performance
Ad

Recommended

11 05-15 Third Quarter 2015 Financial Review Final
11 05-15 Third Quarter 2015 Financial Review Final11 05-15 Third Quarter 2015 Financial Review Final
11 05-15 Third Quarter 2015 Financial Review FinalAES_BigSky
 
Q3 16 slides ugi-v_final
Q3 16 slides ugi-v_finalQ3 16 slides ugi-v_final
Q3 16 slides ugi-v_finalUGI_Corporation
 
Am website presentation november 2016
Am website presentation   november 2016Am website presentation   november 2016
Am website presentation november 2016anteromidstream
 
Q2 16 slides ugi-v_final
Q2 16 slides ugi-v_finalQ2 16 slides ugi-v_final
Q2 16 slides ugi-v_finalUGI_Corporation
 
Management Investor Presentation - Q2 2015
Management Investor Presentation - Q2 2015Management Investor Presentation - Q2 2015
Management Investor Presentation - Q2 2015RioCan
 
Management Investor Presentation - Year End 2015
Management Investor Presentation - Year End 2015Management Investor Presentation - Year End 2015
Management Investor Presentation - Year End 2015RioCan
 
1 q16 earnings-presentation-final
1 q16 earnings-presentation-final1 q16 earnings-presentation-final
1 q16 earnings-presentation-finalinvestorswci
 
Ugi investor day combined_v_final
Ugi investor day combined_v_finalUgi investor day combined_v_final
Ugi investor day combined_v_finalUGI_Corporation
 

More Related Content

What's hot

Q4 16 slides ugi-v_final
Q4 16 slides ugi-v_finalQ4 16 slides ugi-v_final
Q4 16 slides ugi-v_finalUGI_Corporation
 
Q2 2016 operations report final as published
Q2 2016   operations report final as publishedQ2 2016   operations report final as published
Q2 2016 operations report final as publishedEnLinkMidstreamLLC
 
Jp energy barclays mlp corporate access day
Jp energy   barclays mlp corporate access dayJp energy   barclays mlp corporate access day
Jp energy barclays mlp corporate access dayir_jpenergy
 
2q16 earnings presentation-final
2q16 earnings presentation-final2q16 earnings presentation-final
2q16 earnings presentation-finalinvestorswci
 
Q1 16 slides ugi-v_final
Q1 16 slides ugi-v_finalQ1 16 slides ugi-v_final
Q1 16 slides ugi-v_finalAmeriGas
 
En link midstream 3q 2016 operations report final
En link midstream 3q 2016 operations report finalEn link midstream 3q 2016 operations report final
En link midstream 3q 2016 operations report finalEnLinkMidstreamLLC
 
Management Investor Presentation - Q3 2016
Management Investor Presentation - Q3 2016Management Investor Presentation - Q3 2016
Management Investor Presentation - Q3 2016RioCan
 
Investor update march 2016 website
Investor update march 2016 websiteInvestor update march 2016 website
Investor update march 2016 websiteinvestor_phillips66
 
Aksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call PresentationAksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call PresentationAksigorta
 
Q4 fy17 earnings presentation v f
Q4 fy17 earnings presentation v fQ4 fy17 earnings presentation v f
Q4 fy17 earnings presentation v fir_westrock
 
Exhibit 99.2 q3 2016 investor deck final
Exhibit 99.2   q3 2016 investor deck finalExhibit 99.2   q3 2016 investor deck final
Exhibit 99.2 q3 2016 investor deck finalADAESIR
 
REITWeek 2016 Investor Conference
REITWeek 2016 Investor ConferenceREITWeek 2016 Investor Conference
REITWeek 2016 Investor ConferenceIronMInc
 
AES Q2 2016 Financial Review
AES Q2 2016 Financial Review AES Q2 2016 Financial Review
AES Q2 2016 Financial Review AES_BigSky
 
06 26-16 jpm energy conference final
06 26-16 jpm energy conference final06 26-16 jpm energy conference final
06 26-16 jpm energy conference finalAES_BigSky
 
Fy17 q2 slides ugi-v_final
Fy17 q2   slides ugi-v_finalFy17 q2   slides ugi-v_final
Fy17 q2 slides ugi-v_finalUGI_Corporation
 
Trc q1 2015 earnings slides final
Trc q1 2015 earnings slides finalTrc q1 2015 earnings slides final
Trc q1 2015 earnings slides finaltrcsolutions
 
01 05-16 Evercore ISI CEO Retreat Presentation
01 05-16 Evercore ISI CEO Retreat Presentation01 05-16 Evercore ISI CEO Retreat Presentation
01 05-16 Evercore ISI CEO Retreat PresentationAES_BigSky
 
Psx 2017 baml conference presentation final for posting
Psx 2017 baml conference presentation final for postingPsx 2017 baml conference presentation final for posting
Psx 2017 baml conference presentation final for postinginvestor_phillips66
 
yrc worldwide2Q06_release
yrc worldwide2Q06_releaseyrc worldwide2Q06_release
yrc worldwide2Q06_releasefinance41
 

What's hot (20)

Q4 16 slides ugi-v_final
Q4 16 slides ugi-v_finalQ4 16 slides ugi-v_final
Q4 16 slides ugi-v_final
 
4Q 2015 Earnings Conference Call Presentation
4Q 2015 Earnings Conference Call Presentation4Q 2015 Earnings Conference Call Presentation
4Q 2015 Earnings Conference Call Presentation
 
Q2 2016 operations report final as published
Q2 2016   operations report final as publishedQ2 2016   operations report final as published
Q2 2016 operations report final as published
 
Jp energy barclays mlp corporate access day
Jp energy   barclays mlp corporate access dayJp energy   barclays mlp corporate access day
Jp energy barclays mlp corporate access day
 
2q16 earnings presentation-final
2q16 earnings presentation-final2q16 earnings presentation-final
2q16 earnings presentation-final
 
Q1 16 slides ugi-v_final
Q1 16 slides ugi-v_finalQ1 16 slides ugi-v_final
Q1 16 slides ugi-v_final
 
En link midstream 3q 2016 operations report final
En link midstream 3q 2016 operations report finalEn link midstream 3q 2016 operations report final
En link midstream 3q 2016 operations report final
 
Management Investor Presentation - Q3 2016
Management Investor Presentation - Q3 2016Management Investor Presentation - Q3 2016
Management Investor Presentation - Q3 2016
 
Investor update march 2016 website
Investor update march 2016 websiteInvestor update march 2016 website
Investor update march 2016 website
 
Aksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call PresentationAksigorta - 2015 Q3 Financial Results Earnings Call Presentation
Aksigorta - 2015 Q3 Financial Results Earnings Call Presentation
 
Q4 fy17 earnings presentation v f
Q4 fy17 earnings presentation v fQ4 fy17 earnings presentation v f
Q4 fy17 earnings presentation v f
 
Exhibit 99.2 q3 2016 investor deck final
Exhibit 99.2   q3 2016 investor deck finalExhibit 99.2   q3 2016 investor deck final
Exhibit 99.2 q3 2016 investor deck final
 
REITWeek 2016 Investor Conference
REITWeek 2016 Investor ConferenceREITWeek 2016 Investor Conference
REITWeek 2016 Investor Conference
 
AES Q2 2016 Financial Review
AES Q2 2016 Financial Review AES Q2 2016 Financial Review
AES Q2 2016 Financial Review
 
06 26-16 jpm energy conference final
06 26-16 jpm energy conference final06 26-16 jpm energy conference final
06 26-16 jpm energy conference final
 
Fy17 q2 slides ugi-v_final
Fy17 q2   slides ugi-v_finalFy17 q2   slides ugi-v_final
Fy17 q2 slides ugi-v_final
 
Trc q1 2015 earnings slides final
Trc q1 2015 earnings slides finalTrc q1 2015 earnings slides final
Trc q1 2015 earnings slides final
 
01 05-16 Evercore ISI CEO Retreat Presentation
01 05-16 Evercore ISI CEO Retreat Presentation01 05-16 Evercore ISI CEO Retreat Presentation
01 05-16 Evercore ISI CEO Retreat Presentation
 
Psx 2017 baml conference presentation final for posting
Psx 2017 baml conference presentation final for postingPsx 2017 baml conference presentation final for posting
Psx 2017 baml conference presentation final for posting
 
yrc worldwide2Q06_release
yrc worldwide2Q06_releaseyrc worldwide2Q06_release
yrc worldwide2Q06_release
 

Viewers also liked

True Life: I work at an advertising agency
True Life: I work at an advertising agencyTrue Life: I work at an advertising agency
True Life: I work at an advertising agencyKait1788
 
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...Global Business Events
 
Lunar new year celebrations TET QUY TY
Lunar new year celebrations TET QUY TYLunar new year celebrations TET QUY TY
Lunar new year celebrations TET QUY TYvinhbinh2010
 
Aps health care corregida
Aps health care corregidaAps health care corregida
Aps health care corregidasaragagaune
 
How effective is the combination of your main product and ancillary?
How effective is the combination of your main product and ancillary?How effective is the combination of your main product and ancillary?
How effective is the combination of your main product and ancillary?CFGSSufiaB
 
Wikipedia presentation 20130514
Wikipedia presentation 20130514Wikipedia presentation 20130514
Wikipedia presentation 20130514Vassia Atanassova
 
Salesforce dug meetup6_summer14apex
Salesforce dug meetup6_summer14apexSalesforce dug meetup6_summer14apex
Salesforce dug meetup6_summer14apexIkou Sanuki
 
Responsive design patterns
Responsive design patternsResponsive design patterns
Responsive design patternsEdwart Visser
 
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...Knobbe Martens - Intellectual Property Law
 
IT Performance – what differentiates the Leaders
IT Performance – what differentiates the LeadersIT Performance – what differentiates the Leaders
IT Performance – what differentiates the LeadersCapgemini
 
Gráfico diario del ibex 35 para el 15 04 2015
Gráfico diario del ibex 35 para el 15 04 2015Gráfico diario del ibex 35 para el 15 04 2015
Gráfico diario del ibex 35 para el 15 04 2015Experiencia Trading
 

Viewers also liked (13)

True Life: I work at an advertising agency
True Life: I work at an advertising agencyTrue Life: I work at an advertising agency
True Life: I work at an advertising agency
 
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...
Marcos Dussoni, Regional CFO at Sodexo - Acquisitions in complex markets: tak...
 
Lunar new year celebrations TET QUY TY
Lunar new year celebrations TET QUY TYLunar new year celebrations TET QUY TY
Lunar new year celebrations TET QUY TY
 
Aps health care corregida
Aps health care corregidaAps health care corregida
Aps health care corregida
 
How effective is the combination of your main product and ancillary?
How effective is the combination of your main product and ancillary?How effective is the combination of your main product and ancillary?
How effective is the combination of your main product and ancillary?
 
Wikipedia presentation 20130514
Wikipedia presentation 20130514Wikipedia presentation 20130514
Wikipedia presentation 20130514
 
Salesforce dug meetup6_summer14apex
Salesforce dug meetup6_summer14apexSalesforce dug meetup6_summer14apex
Salesforce dug meetup6_summer14apex
 
Responsive design patterns
Responsive design patternsResponsive design patterns
Responsive design patterns
 
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...
10 Strategies Startup Companies Need to Know to Aggressively Build a Patent P...
 
RFID
RFIDRFID
RFID
 
IT Performance – what differentiates the Leaders
IT Performance – what differentiates the LeadersIT Performance – what differentiates the Leaders
IT Performance – what differentiates the Leaders
 
20151020 Metis
20151020 Metis20151020 Metis
20151020 Metis
 
Gráfico diario del ibex 35 para el 15 04 2015
Gráfico diario del ibex 35 para el 15 04 2015Gráfico diario del ibex 35 para el 15 04 2015
Gráfico diario del ibex 35 para el 15 04 2015
 

Similar to Q3 15 earnings slides-final

Q4 15 earnings slides final
Q4 15 earnings slides finalQ4 15 earnings slides final
Q4 15 earnings slides finalInvestorBruker
 
Q1 2015 earnings slides final
Q1 2015 earnings slides finalQ1 2015 earnings slides final
Q1 2015 earnings slides finalInvestorBruker
 
Q2 15 earnings slides-final
Q2 15 earnings slides-finalQ2 15 earnings slides-final
Q2 15 earnings slides-finalInvestorBruker
 
Q3 2014 earnings slides final
Q3 2014 earnings slides finalQ3 2014 earnings slides final
Q3 2014 earnings slides finalInvestorBruker
 
Q4 2014 earnings slides final
Q4 2014 earnings slides finalQ4 2014 earnings slides final
Q4 2014 earnings slides finalInvestorBruker
 
Bruker q1 2014 earnings presentation final
Bruker q1 2014 earnings presentation finalBruker q1 2014 earnings presentation final
Bruker q1 2014 earnings presentation finalInvestorBruker
 
Q4 2013 Earnings Presentation
Q4 2013 Earnings PresentationQ4 2013 Earnings Presentation
Q4 2013 Earnings PresentationInvestorBruker
 
Q2 2014 Earnings Slides
Q2 2014 Earnings SlidesQ2 2014 Earnings Slides
Q2 2014 Earnings SlidesInvestorBruker
 
Q1 16 earnings slides-final
Q1 16 earnings slides-finalQ1 16 earnings slides-final
Q1 16 earnings slides-finalInvestorBruker
 
Q2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationQ2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationInvestorBruker
 
Q215 investor call slides final
Q215 investor call slides finalQ215 investor call slides final
Q215 investor call slides finalbroadwind
 
Bruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesBruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesInvestorBruker
 
TIM Q2 2023 RESULTS
TIM Q2 2023 RESULTSTIM Q2 2023 RESULTS
TIM Q2 2023 RESULTSGruppo TIM
 
TIM-Q2-2023-Results.pdf
TIM-Q2-2023-Results.pdfTIM-Q2-2023-Results.pdf
TIM-Q2-2023-Results.pdfGruppo TIM
 
TIM Q3 ’23 – Delivering and Delayering
TIM Q3 ’23 – Delivering and DelayeringTIM Q3 ’23 – Delivering and Delayering
TIM Q3 ’23 – Delivering and DelayeringGruppo TIM
 
Trc q2 2016 earnings slides final
Trc q2 2016 earnings slides finalTrc q2 2016 earnings slides final
Trc q2 2016 earnings slides finaltrcsolutions
 
FY-2021-Results-2022-24-Plan.pdf
FY-2021-Results-2022-24-Plan.pdfFY-2021-Results-2022-24-Plan.pdf
FY-2021-Results-2022-24-Plan.pdfGruppo TIM
 
2 q14 slides final
2 q14 slides final2 q14 slides final
2 q14 slides finalDupontInv
 
Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18InvestorBruker
 

Similar to Q3 15 earnings slides-final (20)

Q4 15 earnings slides final
Q4 15 earnings slides finalQ4 15 earnings slides final
Q4 15 earnings slides final
 
Q1 2015 earnings slides final
Q1 2015 earnings slides finalQ1 2015 earnings slides final
Q1 2015 earnings slides final
 
Q2 15 earnings slides-final
Q2 15 earnings slides-finalQ2 15 earnings slides-final
Q2 15 earnings slides-final
 
Q3 2014 earnings slides final
Q3 2014 earnings slides finalQ3 2014 earnings slides final
Q3 2014 earnings slides final
 
Q4 2014 earnings slides final
Q4 2014 earnings slides finalQ4 2014 earnings slides final
Q4 2014 earnings slides final
 
Bruker q1 2014 earnings presentation final
Bruker q1 2014 earnings presentation finalBruker q1 2014 earnings presentation final
Bruker q1 2014 earnings presentation final
 
Q4 2013 Earnings Presentation
Q4 2013 Earnings PresentationQ4 2013 Earnings Presentation
Q4 2013 Earnings Presentation
 
Q2 2014 Earnings Slides
Q2 2014 Earnings SlidesQ2 2014 Earnings Slides
Q2 2014 Earnings Slides
 
Q1 16 earnings slides-final
Q1 16 earnings slides-finalQ1 16 earnings slides-final
Q1 16 earnings slides-final
 
Q2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker CorporationQ2 2016 Earnings Presentation - Bruker Corporation
Q2 2016 Earnings Presentation - Bruker Corporation
 
Q215 investor call slides final
Q215 investor call slides finalQ215 investor call slides final
Q215 investor call slides final
 
Bruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings SlidesBruker Q3'18 Earnings Slides
Bruker Q3'18 Earnings Slides
 
Q317 earnings slides
Q317 earnings slidesQ317 earnings slides
Q317 earnings slides
 
TIM Q2 2023 RESULTS
TIM Q2 2023 RESULTSTIM Q2 2023 RESULTS
TIM Q2 2023 RESULTS
 
TIM-Q2-2023-Results.pdf
TIM-Q2-2023-Results.pdfTIM-Q2-2023-Results.pdf
TIM-Q2-2023-Results.pdf
 
TIM Q3 ’23 – Delivering and Delayering
TIM Q3 ’23 – Delivering and DelayeringTIM Q3 ’23 – Delivering and Delayering
TIM Q3 ’23 – Delivering and Delayering
 
Trc q2 2016 earnings slides final
Trc q2 2016 earnings slides finalTrc q2 2016 earnings slides final
Trc q2 2016 earnings slides final
 
FY-2021-Results-2022-24-Plan.pdf
FY-2021-Results-2022-24-Plan.pdfFY-2021-Results-2022-24-Plan.pdf
FY-2021-Results-2022-24-Plan.pdf
 
2 q14 slides final
2 q14 slides final2 q14 slides final
2 q14 slides final
 
Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18Q2'18 earnings slides final 2 aug18
Q2'18 earnings slides final 2 aug18
 

More from InvestorBruker

Q118 earnings slides final 03 may18
Q118 earnings slides final 03 may18Q118 earnings slides final 03 may18
Q118 earnings slides final 03 may18InvestorBruker
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18InvestorBruker
 
Jpm18 hcc brkr-final-05jan18
Jpm18 hcc brkr-final-05jan18Jpm18 hcc brkr-final-05jan18
Jpm18 hcc brkr-final-05jan18InvestorBruker
 
Q217 earnings slides final-03 aug17 (1)
Q217 earnings slides final-03 aug17 (1)Q217 earnings slides final-03 aug17 (1)
Q217 earnings slides final-03 aug17 (1)InvestorBruker
 
Q117 earnings slides final-3 may2017
Q117 earnings slides final-3 may2017Q117 earnings slides final-3 may2017
Q117 earnings slides final-3 may2017InvestorBruker
 
Q416 earnings slides final-13 feb17
Q416 earnings slides final-13 feb17Q416 earnings slides final-13 feb17
Q416 earnings slides final-13 feb17InvestorBruker
 
Bruker jpm2017 hcc fina-lv5.4-08jan17
Bruker jpm2017 hcc fina-lv5.4-08jan17Bruker jpm2017 hcc fina-lv5.4-08jan17
Bruker jpm2017 hcc fina-lv5.4-08jan17InvestorBruker
 
Jp morgan 2016 healthcare conference final
Jp morgan 2016 healthcare conference finalJp morgan 2016 healthcare conference final
Jp morgan 2016 healthcare conference finalInvestorBruker
 
Jp morgan 2015 healthcare conference final
Jp morgan 2015 healthcare conference finalJp morgan 2015 healthcare conference final
Jp morgan 2015 healthcare conference finalInvestorBruker
 

More from InvestorBruker (9)

Q118 earnings slides final 03 may18
Q118 earnings slides final 03 may18Q118 earnings slides final 03 may18
Q118 earnings slides final 03 may18
 
Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18Q417 earnings slides final 08 feb18
Q417 earnings slides final 08 feb18
 
Jpm18 hcc brkr-final-05jan18
Jpm18 hcc brkr-final-05jan18Jpm18 hcc brkr-final-05jan18
Jpm18 hcc brkr-final-05jan18
 
Q217 earnings slides final-03 aug17 (1)
Q217 earnings slides final-03 aug17 (1)Q217 earnings slides final-03 aug17 (1)
Q217 earnings slides final-03 aug17 (1)
 
Q117 earnings slides final-3 may2017
Q117 earnings slides final-3 may2017Q117 earnings slides final-3 may2017
Q117 earnings slides final-3 may2017
 
Q416 earnings slides final-13 feb17
Q416 earnings slides final-13 feb17Q416 earnings slides final-13 feb17
Q416 earnings slides final-13 feb17
 
Bruker jpm2017 hcc fina-lv5.4-08jan17
Bruker jpm2017 hcc fina-lv5.4-08jan17Bruker jpm2017 hcc fina-lv5.4-08jan17
Bruker jpm2017 hcc fina-lv5.4-08jan17
 
Jp morgan 2016 healthcare conference final
Jp morgan 2016 healthcare conference finalJp morgan 2016 healthcare conference final
Jp morgan 2016 healthcare conference final
 
Jp morgan 2015 healthcare conference final
Jp morgan 2015 healthcare conference finalJp morgan 2015 healthcare conference final
Jp morgan 2015 healthcare conference final
 

Recently uploaded

AMG Quarterly Slide deck - February 2024
AMG Quarterly Slide deck - February 2024AMG Quarterly Slide deck - February 2024
AMG Quarterly Slide deck - February 2024gstubel
 
MEOH Investor Presentation - February 2024
MEOH Investor Presentation - February 2024MEOH Investor Presentation - February 2024
MEOH Investor Presentation - February 2024Methanex Corporation
 
Osisko Gold Royalties Ltd - Q4 and Year 2023 Results
Osisko Gold Royalties Ltd - Q4 and Year 2023 ResultsOsisko Gold Royalties Ltd - Q4 and Year 2023 Results
Osisko Gold Royalties Ltd - Q4 and Year 2023 ResultsOsisko Gold Royalties Ltd
 
Teekay Corporation Q4-23 and Annual 2023 ER Document
Teekay Corporation  Q4-23 and Annual 2023 ER DocumentTeekay Corporation  Q4-23 and Annual 2023 ER Document
Teekay Corporation Q4-23 and Annual 2023 ER DocumentTeekay Corporation
 
Presentation BASF Analyst Conference FY2023
Presentation BASF Analyst Conference FY2023Presentation BASF Analyst Conference FY2023
Presentation BASF Analyst Conference FY2023BASF
 
Futures & Options pdf for beginners. .pdf
Futures & Options pdf for beginners.    .pdfFutures & Options pdf for beginners.    .pdf
Futures & Options pdf for beginners. .pdfLuckyChaudhary23
 
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024Osisko Gold Royalties Ltd - Corporate Presentation, February 2024
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024Osisko Gold Royalties Ltd
 
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024HetalMaheshwari4
 
Q4 2023 Conference Call Presentation - February 22, 2024
Q4 2023 Conference Call Presentation - February 22, 2024Q4 2023 Conference Call Presentation - February 22, 2024
Q4 2023 Conference Call Presentation - February 22, 2024TeckResourcesLtd
 
BMO Global Metals, Mining & Critical Minerals conference
BMO Global Metals, Mining & Critical Minerals conferenceBMO Global Metals, Mining & Critical Minerals conference
BMO Global Metals, Mining & Critical Minerals conferenceTeckResourcesLtd
 
Mandalay Resources Corp IR PPT February 2024
Mandalay Resources Corp IR PPT February 2024Mandalay Resources Corp IR PPT February 2024
Mandalay Resources Corp IR PPT February 2024MandalayResources
 
Bladex 4Q23 Earning Results Presentation
Bladex 4Q23 Earning Results PresentationBladex 4Q23 Earning Results Presentation
Bladex 4Q23 Earning Results PresentationBladex
 
Teekay Tankers Q4-23 and Annual 2023 Earnings Presentation
Teekay Tankers Q4-23 and Annual 2023 Earnings PresentationTeekay Tankers Q4-23 and Annual 2023 Earnings Presentation
Teekay Tankers Q4-23 and Annual 2023 Earnings PresentationTeekay Tankers Ltd
 

Recently uploaded (13)

AMG Quarterly Slide deck - February 2024
AMG Quarterly Slide deck - February 2024AMG Quarterly Slide deck - February 2024
AMG Quarterly Slide deck - February 2024
 
MEOH Investor Presentation - February 2024
MEOH Investor Presentation - February 2024MEOH Investor Presentation - February 2024
MEOH Investor Presentation - February 2024
 
Osisko Gold Royalties Ltd - Q4 and Year 2023 Results
Osisko Gold Royalties Ltd - Q4 and Year 2023 ResultsOsisko Gold Royalties Ltd - Q4 and Year 2023 Results
Osisko Gold Royalties Ltd - Q4 and Year 2023 Results
 
Teekay Corporation Q4-23 and Annual 2023 ER Document
Teekay Corporation  Q4-23 and Annual 2023 ER DocumentTeekay Corporation  Q4-23 and Annual 2023 ER Document
Teekay Corporation Q4-23 and Annual 2023 ER Document
 
Presentation BASF Analyst Conference FY2023
Presentation BASF Analyst Conference FY2023Presentation BASF Analyst Conference FY2023
Presentation BASF Analyst Conference FY2023
 
Futures & Options pdf for beginners. .pdf
Futures & Options pdf for beginners.    .pdfFutures & Options pdf for beginners.    .pdf
Futures & Options pdf for beginners. .pdf
 
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024Osisko Gold Royalties Ltd - Corporate Presentation, February 2024
Osisko Gold Royalties Ltd - Corporate Presentation, February 2024
 
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024
Companies (Listing of Equity Shares in permissible Jurisdictions) Rules, 2024
 
Q4 2023 Conference Call Presentation - February 22, 2024
Q4 2023 Conference Call Presentation - February 22, 2024Q4 2023 Conference Call Presentation - February 22, 2024
Q4 2023 Conference Call Presentation - February 22, 2024
 
BMO Global Metals, Mining & Critical Minerals conference
BMO Global Metals, Mining & Critical Minerals conferenceBMO Global Metals, Mining & Critical Minerals conference
BMO Global Metals, Mining & Critical Minerals conference
 
Mandalay Resources Corp IR PPT February 2024
Mandalay Resources Corp IR PPT February 2024Mandalay Resources Corp IR PPT February 2024
Mandalay Resources Corp IR PPT February 2024
 
Bladex 4Q23 Earning Results Presentation
Bladex 4Q23 Earning Results PresentationBladex 4Q23 Earning Results Presentation
Bladex 4Q23 Earning Results Presentation
 
Teekay Tankers Q4-23 and Annual 2023 Earnings Presentation
Teekay Tankers Q4-23 and Annual 2023 Earnings PresentationTeekay Tankers Q4-23 and Annual 2023 Earnings Presentation
Teekay Tankers Q4-23 and Annual 2023 Earnings Presentation
 

Q3 15 earnings slides-final

  • 1. Bruker Corporation (NASDAQ: BRKR) Q3 2015 Earnings Presentation Frank Laukien, President & CEO Anthony Mattacchione, SVP & Interim CFO Joshua Young, VP, IR & Corporate DevelopmentNovember 4, 2015 Innovation with Integrity
  • 2. Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, our ability to successfully implement restructuring initiatives, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, realization of anticipated benefits from economic stimulus programs, intellectual property rights, litigation, and exposure to foreign currency fluctuations and other risk factors discussed from time to time in our filings with the Securities and Exchange Commission. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2014 and our quarterly reports on Form 10-Q for the periods ended March 31, 2015 and June 30, 2015. We will also be referencing non-GAAP financial measures in this presentation. A reconciliation of non-GAAP to GAAP results is available in our earnings press release and in this presentation. Bruker Corporation Safe Harbor & Reg. G Statement © Bruker Corporation 2
  • 3. Q3-15 & YTD 2015 Business Update © Bruker Corporation 3
  • 4. $0.14 $0.19 Q3-14 Q3-15 Q3 Financials Revenues [$ m] Non-GAAP EPS Bruker delivers stronger, more balanced financial performance in Q3 2015 -6% +36% © Bruker Corporation 4 420 396 Q3-14 Q3-15 Q3 2015 Performance  Revenues decline -$24m, or -6% y-o-y − FX headwinds lower revenue -11% y-o-y  Organic revenue growth of +8% y-o-y, driven by CALID and BioSpin Groups − Europe & Asia are strongest regions  Non-GAAP operating margins expand by +470 basis points y-o-y  Non-GAAP EPS grows by +36% y-o-y despite higher tax rate  Free cash flow of $45M in Q3-15 up compared to $4M in Q3-14 − Higher profitability and lower working capital drive FCF improvement
  • 5. $0.46 $0.51 YTD 2014 YTD 2015 YTD Financials Revenues [$ m] Non-GAAP EPS Q3-YTD Bruker is on track for a year of good margin expansion, earnings growth and cash flow generation -12% +11% © Bruker Corporation 5 1,301 1,146 YTD 14 YTD 15 Q3 YTD 2015 Performance  Revenues decline -12% y-o-y  Organic revenue growth of +2% y-o-y 1.High-single digit organic revenue growth from CALID Group; low single digit organic revenue growth in NANO Group 2.Low single digit organic revenue decline in BioSpin Group 3.Europe and Asia drive YTD organic growth  Non-GAAP operating margin expands by +220 basis points y-o-y, including +115 basis points due to CAM restructuring in 2014  Reported non-GAAP EPS grows +11%  Free cash flow of $57M increases by +$39 million, compared to $18M in Q3 YTD 2014
  • 6. Bruker BIOSPIN Group  Strong revenue growth for Nuclear Magnetic Resonance (NMR) as business rebounds in all major geographies  NMR business recovery continues as order bookings remain healthy  Preclinical imaging business reports mid-single digit organic growth in Q3-15, but YTD weakness in order bookings continues  Positive product mix, benefits from restructuring, higher-margin transactions, earlier than expected customer acceptances drive improved margins Bruker CALID Group  Delivers double-digit organic revenue growth y-o-y with strong performance in Europe and Asia, and with strong margin expansion  Daltonics Division drives organic revenue growth in nearly all product lines and geographies  Detection Division generates exceptional, but non-recurring revenue growth in Q3-15 with new explosives trace detection products  Optics Division experiences flat organic revenues due to restrained demand from industrial and high-end R&D customers 6© Bruker Corporation GROUP OVERVIEW: Q3 2015 Performance
  • 7. Bruker NANO Group  Organic revenue and bookings decline due to weaker demand from most industrial market segments  AXS Division posts mid-single digit organic revenue growth: strong demand for X-ray diffraction products and improved execution  Nano Surfaces Division revenues decline primarily due to weak industrial, semiconductor and data storage customers  Acquisition of Jordan Valley Semiconductor (at end of October 2015) will enable Bruker to capitalize on secular trends of smaller feature sizes and 3D structures in semiconductor metrology market BEST Segment  Achieved almost 10% non-GAAP operating margin  ROSATOM pilot line acceptance shifted to Q4-15  Q3-15 YTD organic bookings growth >20% y-o-y GROUP OVERVIEW: Q3 2015 Performance 7© Bruker Corporation
  • 8. 8 A9 processor 14nm FinFET Xeon + FPGA for Data Center 10nm FinFET 3D packaging Social Media Cloud Computing Wearable/Portable Electronics V - NAND 3D NAND Acquisition of Jordan Valley Semiconductor closed enables new Bruker Semiconductor Division to capitalize on semi trends to 3D features & smaller size nodes for: © Bruker Corporation
  • 9. Key Messages after Q3 2015: © Bruker Corporation 9 Bruker is on track to meet or exceed its FY15 guidance for organic revenue growth, margin expansion and EPS BIOSPIN Group is recovering after a weak start in H1 2015 CALID Group is successfully driving the adoption of new products and generating higher growth and margins We are attracting top-notch senior managers and board members
  • 10. Q3 2015 Financial Update © Bruker Corporation 10
  • 11. NON-GAAP FINANCIAL PERFORMANCE: Q3 2015 Overview [$ m, except EPS] Q3 2015 Q3 2014 Δ Revenues 396.1 419.8 -6% Operating Income 52.8 35.9 47% Margin (%) 13.3% 8.6% EPS $0.19 $0.14 36% Free Cash Flow 44.7 3.6 41.1M  Strong operating margin expansion aided by an easy Q3-14 comparison and absence of CAM results  Strong cash flow generation driven by operational improvements and tax refunds  Working capital ratios continue to improve 11© Bruker Corporation COMMENTS [$ m] Sep 30, 2015 Sep 30, 2014 Δ Net Cash 160.9 87.1 85% Working capital (WC)* 633.2 737.2 -14% WC-to-revenue ratio 0.38 0.40 -0.02 * WC = (Accounts Receivable + Inventory – Accounts Payable)
  • 12. Q3 2014 Organic Currency Divestitures Q3 2015 $419.8M $396.1M Q3 2015 revenue bridge  CALID and BioSpin Group drive organic revenue increase  Strong currency headwinds 12© Bruker Corporation Q3 2015 DRIVERS Q3 2015 Revenue Bridge [$ m] +$33.2 -$45.8 -$11.1 Organic Currency Divestitures Total 8.1% -10.9% -2.8% -5.6% Q3 2015 Revenue for Bruker Corp.
  • 13. Q3 2015 Non-GAAP Results  Gross margin improvement is primarily the result of increased volume, positive product mix, restructuring actions, and the absence of CAM results  Lower operating expenses due to FX translation and absence of CAM results  Higher tax rate is the result of changes in jurisdictional mix, including lower US pre- tax profits  FX headwinds lower EPS by (-$0.02) in Q3-15 13© Bruker Corporation COMMENTS[$ m, except EPS] Q3 2015 Q3 2014 Δ Total Revenues 396.1 419.8 -6% Gross Profit 182.7 185.5 -2% Margin (% of revenues) 46.1% 44.2% SG&A -95.6 -107.5 -11% (% of revenues) 24.1% 25.6% R&D -34.3 -42.1 -19% (% of revenues) 8.7% 10.0% Operating Income 52.8 35.9 47% (% of revenues) 13.3% 8.6% Tax Rate 32.2% 27.0% 520 bps Net Income* 31.6 23.8 33% EPS $0.19 $0.14 36% Shares Outstanding 168.7 169.6 NM * Attributable to BrukerSum of items may not total due to rounding
  • 14. Q3 2015 Reconciliation of GAAP and Non-GAAP Results [$ m, except EPS] Q3 2015 Q3 2014 GAAP Operating Income 28.2 4.9 Restructuring Costs 12.7 16.2 Acquisition-Related Costs 1.2 1.4 Purchased Intangible Amortization 5.1 5.1 Other Costs 5.6 8.3 TOTAL 24.6 31.0 Non-GAAP Operating Income 52.8 35.9 Non-GAAP Interest & Other Income (Expense), net* -4.6 -2.2 Non GAAP Profit* Before Tax 48.2 33.7 Non-GAAP Income Tax Provision -15.5 -9.1 Non-GAAP Tax Rate 32.2% 27.0% Minority Interest -1.1 -0.8 Non-GAAP Net Income** 31.6 23.8 Non-GAAP EPS $0.19 $0.14 14© Bruker Corporation Sum of items may not total due to rounding *Excludes $6.3M of net gains for 2014 **Attributable to Bruker
  • 15. Q3-14 YTD Organic Currency Divestitures Q3-15 YTD $1,300.9M $1,145.6M Q3-15 YTD revenue bridge  Organic revenue growth of 1.9% driven by CALID Group  Europe is strongest region on YTD basis 15© Bruker Corporation Q3-15 YTD DRIVERS Q3-15 YTD Revenue Bridge [$ m] +$23.9 -$145.2 -$34.0 Organic Currency Divestitures Total 1.9% -11.1% -2.7% -11.9% Q3-15 YTD Revenue for Bruker Corp.
  • 16. Q3-15 YTD Non-GAAP Results  CALID drives most of gross margin improvement – CAM divestments in 2014 add +64 bps to gross margin  -$67M reduction in opex related to FX translation and absence of CAM results  Non-GAAP operating margin increases by +220 bps  Non-GAAP EPS headwind of (-$0.07) from FX 16© Bruker Corporation COMMENTS[$ m, except EPS] Q3-15 YTD Q3-14 YTD Δ Total Revenues 1,145.6 1,300.9 -12% Gross Profit 528.2 584.5 -10% Margin (% of revenues) 46.1% 44.9% SG&A -287.7 -331.2 -13% (% of revenues) 25.1% 25.5% R&D -109.0 -132.6 -18% (% of revenues) 9.5% 10.2% Operating Income 131.5 120.7 9% (% of revenues) 11.5% 9.3% Tax Rate 23.9% 28.0% -410 bps Net Income* 86.6 77.4 12% EPS $0.51 $0.46 11% Shares Outstanding 169.1 169.5 NM * Attributable to BrukerSum of items may not total due to rounding
  • 17. Q3-15 YTD Reconciliation of GAAP and Non-GAAP Results [$ m, except EPS] Q3-15 YTD Q3-14 YTD GAAP Operating Income 75.0 60.9 Restructuring Costs 21.2 29.3 Acquisition-Related Costs -1.4 3.0 Purchased Intangible Amortization 15.5 15.1 Other Costs 21.2 12.4 TOTAL 56.5 59.8 Non-GAAP Operating Income 131.5 120.7 Non-GAAP Interest & Other Income (Expense), net* -14.1 -9.7 Non-GAAP Profit* Before Tax 117.4 111.0 Non-GAAP Income Tax Provision -28.1 -31.1 Non-GAAP Tax Rate 23.9% 28.0% Minority Interest -2.7 -2.5 Non-GAAP Net Income** 86.6 77.4 Non-GAAP EPS $0.51 $0.46 17© Bruker Corporation * Excludes $0.2M of net losses for 2015 and $6.6M of net gains for 2014 **Attributable to BrukerSum of items may not total due to rounding
  • 18. Q3-15 Cash Flow Statement  Higher gross margins, lower restructuring costs result in higher net income  Working capital efficiency continues to improve  “Other” increases as a source of cash mostly due to tax refunds and operational improvements 18© Bruker Corporation COMMENTS[$ m] Q3 2015 Q3 2014 Δ Net Income 12.9 6.3 6.6 Depreciation & amortization 13.3 17.6 -4.3 Changes in working capital* -3.0 -16.0 13.0 Other 30.9 5.6 25.3 Operating cash flow 54.1 13.5 40.6 Capital expenditures -9.4 -9.9 0.5 Free cash flow 44.7 3.6 41.1
  • 19. Full Year 2015 Outlook © Bruker Corporation 19
  • 20. Updated FY 2015 Guidance Organic Revenue Growth Approximately +1% Non-GAAP Operating Margin Expansion y-o-y >150 bps Non-GAAP EPS $0.75 - $0.80 20© Bruker Corporation We are increasing our FY-2015 Guidance  Changes in currency reduce revenues by (-10%)  FX generates -13% or (-$0.10) headwind to non-GAAP EPS in 2015  CAM revenues decrease by ~$50M in 2015  FY 2015 tax rate: ~24%-25%  Current currency assumptions: Yen/USD: 120 USD/EUR: 1.12 2015 ASSUMPTIONS
  • 22. Q3 2015 GAAP Results [$ m, except EPS] Q3 2015 Q3 2014 Δ Total Revenues 396.1 419.8 -6% Gross Profit 167.5 167.3 NM Margin (% of sales) 42.3% 39.9% SG&A -96.1 -108.0 -11% (% of revenues) 24.3% 25.7% R&D -34.3 -42.1 -19% (% of revenues) 8.7% 10.0% Operating Income 28.2 4.9 476% (% of revenues) 7.1% 1.2% Net Income* 11.8 5.5 115% EPS $0.07 $0.03 133% Shares Outstanding 168.7 169.6 NM 22© Bruker Corporation * Attributable to BrukerSum of items may not total due to rounding
  • 23. Balance sheet [$ m] Sep 30, 2015 Sep 30, 2014 Dec 31, 2014 Cash, Cash Equivalents & Short-term Investments 532.3 442.3 497.5 Financial Debt 371.4 355.2 355.0 Net Cash 160.9 87.1 142.5 23© Bruker Corporation [$ m] Sep 30, 2015 Sep 30, 2014 Dec 31, 2014 Total Assets 1,842.9 1,910.6 1,864.8 Working Capital* 633.2 737.2 694.6 Intangibles, Net & Other Long-Term Assets 224.1 245.9 248.6 * WC = (Accounts Receivable + Inventory - Accounts Payable)
  • 24. Q3-15 YTD GAAP Results [$ m, except EPS] Q3-15 YTD Q3-14 YTD Δ Total Revenues 1,145.6 1,300.9 -12% Gross Profit 497.1 547.5 -9% Margin (% of sales) 43.4% 42.1% SG&A -289.2 -332.5 -13% (% of revenues) 25.2% 25.6% R&D -109.0 -132.6 -18% (% of revenues) 9.5% 10.2% Operating Income 75.0 60.9 23% (% of revenues) 6.5% 4.7% Net Income* 40.2 30.6 31% EPS $0.24 $0.18 33% Shares Outstanding 169.1 169.5 NM 24© Bruker Corporation * Attributable to BrukerSum of items may not total due to rounding
  • 25. Q3-15 YTD Cash Flow Statement [$ m] Q3-15 YTD Q3-14 YTD Δ Net Income 42.9 33.1 9.8 Depreciation & amortization 40.0 47.6 -7.6 Changes in working capital* 11.4 2.8 8.6 Other -14.7 -38.5 23.8 Operating cash flow 79.6 45.0 34.6 Capital expenditures -22.8 -26.7 3.9 Free cash flow 56.8 18.3 38.5 25© Bruker Corporation
  • 26. Q3-15 GAAP SEGMENT RESULTS: BSI and BEST GAAP Performance [$ m] Q3 2015 Q3 2014 Δ REVENUE Scientific Instruments (BSI) 366.6 383.4 -4% Organic Revenue Growth (%) 9.3% -7.1% Energy & Supercon Technologies (BEST) 32.9 40.0 -18% Organic Revenue Growth (%) -2.6% 22.6% Corporate Eliminations -3.4 -3.6 Total Revenue 396.1 419.8 -6% OPERATING INCOME Scientific Instruments (BSI) 25.8 0.8 NM Energy & Supercon Technologies (BEST) 2.5 3.9 -36% Corporate Eliminations -0.1 0.2 Total Operating Income 28.2 4.9 476% 26© Bruker Corporation Sum of items may not total due to rounding